within Pharmacolibrary.Drugs.ATC.N;

model N05AD08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 9.5 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Droperidol is a butyrophenone antipsychotic agent primarily used as an antiemetic for the prevention and treatment of postoperative nausea and vomiting, and for premedication, sedation, and induction of anesthesia. It has also been used for the management of acute agitation. Its clinical use has diminished in some regions due to concerns over QT prolongation and potential cardiac arrhythmias, but it remains approved in several countries.</p><h4>Pharmacokinetics</h4><p>Adult patients (both sexes), healthy volunteers, intravenous (IV) bolus administration.</p><h4>References</h4><ol><li><p>Cooper, I, et al., &amp; Graudins, A (2018). The pharmacokinetics of intranasal droperidol in volunteers characterised via population modelling. <i>SAGE open medicine</i> 6 2050312118813283–None. DOI:<a href=&quot;https://doi.org/10.1177/2050312118813283&quot;>10.1177/2050312118813283</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30574300/&quot;>https://pubmed.ncbi.nlm.nih.gov/30574300</a></p></li><li><p>Fischler, M, et al., &amp; Vourc&#x27;h, G (1986). The pharmacokinetics of droperidol in anesthetized patients. <i>Anesthesiology</i> 64(4) 486–489. DOI:<a href=&quot;https://doi.org/10.1097/00000542-198604000-00012&quot;>10.1097/00000542-198604000-00012</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3963455/&quot;>https://pubmed.ncbi.nlm.nih.gov/3963455</a></p></li><li><p>McKeage, K, et al., &amp; Wagstaff, AJ (2006). Intravenous droperidol: a review of its use in the management of postoperative nausea and vomiting. <i>Drugs</i> 66(16) 2123–2147. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200666160-00009&quot;>10.2165/00003495-200666160-00009</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17112307/&quot;>https://pubmed.ncbi.nlm.nih.gov/17112307</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N05AD08;
